ClinicalTrials.gov
public full text
Public Domain
Safety Study of AMG 228 to Treat Solid Tumors
advanced-solid-tumorscancercolorectal-cancermelanomanon-small-cell-lung-cancernon-small-cell-lung-cancer-nsclconcologytumors
The purpose of this study is to evaluate the safety, pharmacokinetics, anti-tumor activity, and identify a tolerable dose of AMG 228 in subjects with advanced solid tumors.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of MG2512 Injection in Participants With Advanced Solid Tumors#851102
- A Phase I Study on ReT01 ACT for the Treatment of Advanced Solid Tumors#827498
- A Dose Escalation Study of MLN7243 (TAK-243) in Adult Participants With Advanced Solid Tumors#866475
- Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors#1075456
- A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17#800173
Record · ID 1047394
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive